CDH5 and neoplasm: Tumour‐derived molecules such as ADAM17, miR‐27b‐3p and miR‐25‐3p compromise the integrity of the endothelial barrier by targeting ZO‐1, occludin, claudin and VE‐cadherin, thereby promoting vascular permeability.51, 52, 53